PCSK9 drives sterol-dependent metastatic organ choice in pancreatic cancer
Gilles Rademaker(University of California, San Francisco), Rushika M. Perera(University of California, San Francisco)
Cited by 30
Related Papers
Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism
|Nature|2015|788
Treatment of Human Tumor Xenografts with Monoclonal Antibody 806 in Combination with a Prototypical Epidermal Growth Factor Receptor–Specific Antibody Generates Enhanced Antitumor Activity
|Clinical Cancer Research|2005|103